Trinidad et al. [92] found that knockout of PDK4 could down-regulate the expression of the mutant oncogene KRAS, thereby inhibiting cell growth of lung cancer and colorectal cancer (CRC) cells, indicating that PDK4 is an attractive target for cancer treatment. Here, PDK4 is linked to lung cancer.